Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism

eLife

Volumn 5, Issue FEBRUARY2016, 2016, Pages

  Zhao, Hongyun ^a,b   Yang, Lifeng ^a,b   Baddour, Joelle ^a,b   Achreja, Abhinav ^a,b   Bernard, Vincent ^c   Moss, Tyler ^c   Marini, Juan C ^d   Tudawe, Thavisha ^b   Seviour, Elena G ^c   San Lucas, F Anthony ^c   Alvarez, Hector ^c   Gupta, Sonal ^c   Maiti, Sourindra N ^c   Cooper, Laurence ^c   Peehl, Donna ^e   Ram, Prahlad T ^c   Maitra, Anirban ^c   Nagrath, Deepak ^a,b  

^a RICE UNIVERSITY   (United States)

^b Rice University   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; AMINO ACID; GLUTAMINE; K RAS PROTEIN; LACTIC ACID; LIPID; MICRORNA; GLUCOSE;

ACIDIFICATION; ARTICLE; CANCER ASSOCIATED FIBROBLAST; CANCER CELL; CARBOXYLATION; CELL METABOLISM; CELL SIZE; CELL VIABILITY; CITRIC ACID CYCLE; CONTROLLED STUDY; DOWN REGULATION; EXOSOME; FIBROBLAST; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GLUCOSE METABOLISM; GLYCOLYSIS; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; ISOTOPE LABELING; METABOLITE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; NEOPLASM; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; PHENOTYPE; PINOCYTOSIS; PLEIOTROPY; PROSTATE CANCER; REAL TIME POLYMERASE CHAIN REACTION; TUMOR MICROENVIRONMENT; UPREGULATION; FERMENTATION; METABOLISM; PATHOPHYSIOLOGY;

EXOSOMES; FERMENTATION; FIBROBLASTS; GLUCOSE; GLYCOLYSIS; LACTIC ACID; NEOPLASMS; OXIDATIVE PHOSPHORYLATION; TUMOR MICROENVIRONMENT;

EID: 84964445423     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.10250     Document Type: Article

References (60)

1. Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, Huang H, Porter D, Hu M, Chin L, Richardson A, Schnitt S, Sellers WR, Polyak K. 2004. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 6: 17-32. doi: 10.1016/j.ccr.2004.06.010
2. Brauer HA, Makowski L, Hoadley KA, Casbas-Hernandez P, Lang LJ, Roman-Perez E, D’Arcy M, Freemerman AJ, Perou CM, Troester MA. 2013. Impact of Tumor Microenvironment and Epithelial Phenotypes on Metabolism in Breast Cancer. Clinical Cancer Research 19: 571-585. doi: 10.1158/1078-0432.CCR-12-2123
3. Cairns RA, Harris IS, Mak TW. 2011. Regulation of cancer cell metabolism. Nature Reviews Cancer 11: 85-95. doi: 10.1038/nrc2981
4. Casella JF, Flanagan MD, Lin S. 1981. Cytochalasin D inhibits actin polymerization and induces depolymerization of actin filaments formed during platelet shape change. Nature 293: 302-305. doi: 10.1038/293302a0
5. Christianson HC, Svensson KJ, van Kuppevelt TH, Li J-P, Belting M. 2013. Cancer cell exosomes depend on cell-surface heparan sulfate proteoglycans for their internalization and functional activity. Proceedings of the National Academy of Sciences 110: 17380-17385. doi: 10.1073/pnas.1304266110
6. Chung LWK, Huang W-C, Sung S-Y, Wu D, Odero-Marah V, Nomura T, Shigemura K, Miyagi T, Seo S, Shi C, Molitierno J, Elmore J, Anderson C, Isotani S, Edlund M, Hsieh C-L, Wang R, Shehata B, Zhau HE. 2006. Stromal-Epithelial Interaction in Prostate Cancer Progression. Clinical Genitourinary Cancer 5: 162-170. doi: 10. 3816/CGC.2006.n.034
7. Commisso C, Davidson SM, Soydaner-Azeloglu RG, Parker SJ, Kamphorst JJ, Hackett S, Grabocka E, Nofal M, Drebin JA, Thompson CB, Rabinowitz JD, Metallo CM, Vander Heiden MG, Bar-Sagi D. 2013. Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells. Nature 497: 633-637. doi: 10.1038/nature12138
8. Costa-Silva B, Aiello NM, Ocean AJ, Singh S, Zhang H, Thakur BK, Becker A, Hoshino A, Mark MT, Molina H, Xiang J, Zhang T, Theilen T-M, García-Santos G, Williams C, Ararso Y, Huang Y, Rodrigues G, Shen T-L, Labori KJ, et al. 2015. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nature Cell Biology 17: 816-826. doi: 10.1038/ncb3169
9. Dang CV. 2010. Glutaminolysis: Supplying carbon or nitrogen or both for cancer cells? Cell Cycle 9: 3884-3886. doi: 10.4161/cc.9.19.13302
10. Daye D, Wellen KE. 2012. Metabolic reprogramming in cancer: Unraveling the role of glutamine in tumorigenesis. Seminars in Cell & Developmental Biology 23: 362-369. doi: 10.1016/j.semcdb.2012.02.002
11. De Schrijver E, Brusselmans K, Heyns W, Verhoeven G, Swinnen JV. 2003. RNA interference-mediated silencing of the fatty acid synthase gene attenuates growth and induces morphological changes and apoptosis of LNCaP prostate cancer cells. Cancer Research 63: 3799-3804.
12. DeBerardinis RJ, Cheng T. 2010. Q’s next: the diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene 29: 313-324. doi: 10.1038/onc.2009.358
13. Delinassios JG. 1987. Fibroblasts against cancer cells in vitro. Anticancer Research 7: 1005-1010.
14. Ekström K, Valadi H, Sjöstrand M, Malmhäll C, Bossios A, Eldh M, Lötvall J. 2012. Characterization of mRNA and microRNA in human mast cell-derived exosomes and their transfer to other mast cells and blood CD34 progenitor cells. Journal of Extracellular Vesicles 1. doi: 10.3402/jev.v1i0.18389
15. Feig C, Gopinathan A, Neesse A, Chan DS, Cook N, Tuveson DA. 2012. The Pancreas Cancer Microenvironment. Clinical Cancer Research 18: 4266-4276. doi: 10.1158/1078-0432.CCR-11-3114
16. Fendt S-M, Bell EL, Keibler MA, Olenchock BA, Mayers JR, Wasylenko TM, Vokes NI, Guarente L, Heiden MGV, Stephanopoulos G. 2013. Reductive glutamine metabolism is a function of the a-ketoglutarate to citrate ratio in cells. Nature Communications 4: 2236. doi: 10.1038/ncomms3236
17. Feng D, Zhao W-L, Ye Y-Y, Bai X-C, Liu R-Q, Chang L-F, Zhou Q, Sui S-F. 2010. Cellular Internalization of Exosomes Occurs Through Phagocytosis. Traffic 11: 675-687. doi: 10.1111/j.1600-0854.2010.01041.x
18. Feron O. 2009. Pyruvate into lactate and back: From the Warburg effect to symbiotic energy fuel exchange in cancer cells. Radiotherapy and Oncology 92: 329-333. doi: 10.1016/j.radonc.2009.06.025
19. Fiaschi T, Chiarugi P. 2012. Oxidative Stress, Tumor Microenvironment, and Metabolic Reprogramming: A Diabolic Liaison. International Journal of Cell Biology 2012: 1-8. doi: 10.1155/2012/762825
20. Gaglio D, Soldati C, Vanoni M, Alberghina L, Chiaradonna F. 2009. Glutamine Deprivation Induces Abortive S-Phase Rescued by Deoxyribonucleotides in K-Ras Transformed Fibroblasts. PLoS ONE 4: e4715. doi: 10.1371/journal.pone.0004715
21. Gangoda L, Boukouris S, Liem M, Kalra H, Mathivanan S. 2015. Extracellular vesicles including exosomes are mediators of signal transduction: are they protective or pathogenic? Proteomics 15: 260-331. doi: 10.1002/pmic.201400234
22. Gatenby RA, Gawlinski ET, Gmitro AF, Kaylor B, Gillies RJ. 2006. Acid-Mediated Tumor Invasion: a Multidisciplinary Study. Cancer Research 66: 5216-5223. doi: 10.1158/0008-5472.CAN-05-4193
23. Hazlehurst LA, Landowski TH, Dalton WS. 2003. Role of the tumor microenvironment in mediating de novo resistance to drugs and physiological mediators of cell death. Oncogene 22: 7396-7402. doi: 10.1038/sj.onc. 1206943
24. Hoshino A, Costa-Silva B, Shen T-L, Rodrigues G, Hashimoto A, Tesic Mark M, Molina H, Kohsaka S, Di Giannatale A, Ceder S, Singh S, Williams C, Soplop N, Uryu K, Pharmer L, King T, Bojmar L, Davies AE, Ararso Y, Zhang T, et al. 2015. Tumour exosome integrins determine organotropic metastasis. Nature 527: 329-335. doi: 10.1038/nature15756
25. Hu Y, Yan C, Mu L, Huang K, Li X, Tao D, Wu Y, Qin J. 2015. Fibroblast-Derived Exosomes Contribute to Chemoresistance through Priming Cancer Stem Cells in Colorectal Cancer. PLOS ONE 10: e0125625. doi: 10. 1371/journal.pone.0125625
26. Ishikawa K, Takenaga K, Akimoto M, Koshikawa N, Yamaguchi A, Imanishi H, Nakada K, Honma Y, Hayashi J-I. 2008. ROS-Generating Mitochondrial DNA Mutations Can Regulate Tumor Cell Metastasis. Science 320: 661-664. doi: 10.1126/science.1156906
27. Johnson AT, Kaufmann YC, Luo S, Todorova V, Klimberg VS. 2003. Effect of glutamine on glutathione, IGF-I, and TGF-b1. Journal of Surgical Research 111: 222-228. doi: 10.1016/S0022-4804(03)00083-0
28. Johnstone RM, Adam M, Hammond JR, Orr L, Turbide C. 1987. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). The Journal of Biological Chemistry 262: 9412-9420.
29. Kamphorst JJ, Chung MK, Fan J, Rabinowitz JD. 2014. Quantitative analysis of acetyl-CoA production in hypoxic cancer cells reveals substantial contribution from acetate. Cancer & Metabolism 2: 23. doi: 10.1186/2049-3002-2-23
30. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, Richardson AL, Polyak K, Tubo R, Weinberg RA. 2007. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449: 557-563. doi: 10.1038/nature06188
31. Kharroubi AT, Masterson TM, Aldaghlas TA, Kennedy KA, Kelleher JK. 1992. Isotopomer spectral analysis of triglyceride fatty acid synthesis in 3T3-L1 cells. The American Journal of Physiology 263: E667-675.
32. King A, Selak MA, Gottlieb E. 2006. Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer. Oncogene 25: 4675-4682. doi: 10.1038/sj.onc.1209594
33. Koukourakis MI, Giatromanolaki A, Sivridis E, Gatter KC, Harris AL. Tumor and Angiogenesis Research Group. 2005. Pyruvate Dehydrogenase and Pyruvate Dehydrogenase Kinase Expression in Non Small Cell Lung Cancer and Tumor-Associated Stroma. Neoplasia 7: 1-6. doi: 10.1593/neo.04373
34. Li J-H, Liu S, Zhou H, Qu L-H, Yang J-H. 2014. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Research 42: D92-D97. doi: 10.1093/nar/gkt1248
35. Liao D, Luo Y, Markowitz D, Xiang R, Reisfeld RA. 2009. Cancer Associated Fibroblasts Promote Tumor Growth and Metastasis by Modulating the Tumor Immune Microenvironment in a 4T1 Murine Breast Cancer Model. PLoS ONE 4: e7965. doi: 10.1371/journal.pone.0007965
36. Metallo CM, Gameiro PA, Bell EL, Mattaini KR, Yang J, Hiller K, Jewell CM, Johnson ZR, Irvine DJ, Guarente L, Kelleher JK, Vander Heiden MG, Iliopoulos O, Stephanopoulos G. 2012. Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature 481: 380-384. doi: 10.1038/nature10602
37. Modica-Napolitano JS, Singh KK. 2004. Mitochondrial dysfunction in cancer. Mitochondrion 4: 755-762. doi: 10. 1016/j.mito.2004.07.027
38. Mullen AR, Wheaton WW, Jin ES, Chen P-H, Sullivan LB, Cheng T, Yang Y, Linehan WM, Chandel NS, DeBerardinis RJ. 2012. Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature 481: 385-388. doi: 10.1038/nature10642
39. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL, Weinberg RA. 2005. Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion. Cell 121: 335-348. doi: 10.1016/j.cell.2005.02.034
40. Pizer ES, Jackisch C, Wood FD, Pasternack GR, Davidson NE, Kuhajda FP. 1996. Inhibition of fatty acid synthesis induces programmed cell death in human breast cancer cells. Cancer Research 56: 2745-2747.
41. Rajagopalan KN, DeBerardinis RJ. 2011. Role of Glutamine in Cancer: Therapeutic and Imaging Implications. Journal of Nuclear Medicine 52: 1005-1008. doi: 10.2967/jnumed.110.084244
42. Rattigan YI, Patel BB, Ackerstaff E, Sukenick G, Koutcher JA, Glod JW, Banerjee D. 2012. Lactate is a mediator of metabolic cooperation between stromal carcinoma associated fibroblasts and glycolytic tumor cells in the tumor microenvironment. Experimental Cell Research 318: 326-335. doi: 10.1016/j.yexcr.2011.11.014
43. Saifer A, Palo J. 1969. Amino acid composition of monomeric and polymeric human serum albumin. Analytical Biochemistry 27: 1-14. doi: 10.1016/0003-2697(69)90214-0
44. Salimian Rizi B, Caneba C, Nowicka A, Nabiyar AW, Liu X, Chen K, Klopp A, Nagrath D. 2015. Nitric oxide mediates metabolic coupling of omentum-derived adipose stroma to ovarian and endometrial cancer cells. Cancer Research 75: 456-527. doi: 10.1158/0008-5472.CAN-14-1337
45. Santidrian AF, Matsuno-Yagi A, Ritland M, Seo BB, LeBoeuf SE, Gay LJ, Yagi T, Felding-Habermann B. 2013. Mitochondrial complex I activity and NAD+/NADH balance regulate breast cancer progression. Journal of Clinical Investigation 123: 1068-1081. doi: 10.1172/JCI64264
46. Selak MA, Armour SM, MacKenzie ED, Boulahbel H, Watson DG, Mansfield KD, Pan Y, Simon MC, Thompson CB, Gottlieb E. 2005. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-a prolyl hydroxylase. Cancer Cell 7: 77-85. doi: 10.1016/j.ccr.2004.11.022
47. Shanware NP, Mullen AR, DeBerardinis RJ, Abraham RT. 2011. Glutamine: pleiotropic roles in tumor growth and stress resistance. Journal of Molecular Medicine 89: 229-236. doi: 10.1007/s00109-011-0731-9
48. Simons M, Raposo G. 2009. Exosomes - vesicular carriers for intercellular communication. Current Opinion in Cell Biology 21: 575-581. doi: 10.1016/j.ceb.2009.03.007
49. Warburg O, Wind F, Negelein E. 1927. The metabolism of tumors in the body. The Journal of General Physiology 8: 519-530. doi: 10.1085/jgp.8.6.519
50. Weinberg F, Hamanaka R, Wheaton WW, Weinberg S, Joseph J, Lopez M, Kalyanaraman B, Mutlu GM, Budinger GRS, Chandel NS. 2010. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proceedings of the National Academy of Sciences 107: 8788-8793. doi: 10.1073/pnas. 1003428107
51. Whiteside TL. 2008. The tumor microenvironment and its role in promoting tumor growth. Oncogene 27: 5904-5912. doi: 10.1038/onc.2008.271
52. Wise DR, DeBerardinis RJ, Mancuso A, Sayed N, Zhang X-Y, Pfeiffer HK, Nissim I, Daikhin E, Yudkoff M, McMahon SB, Thompson CB. 2008. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proceedings of the National Academy of Sciences 105: 18782-18787. doi: 10.1073/pnas.0810199105
53. Wise DR, Thompson CB. 2010. Glutamine addiction: a new therapeutic target in cancer. Trends in Biochemical Sciences 35: 427-433. doi: 10.1016/j.tibs.2010.05.003
54. Wise DR, Ward PS, Shay JES, Cross JR, Gruber JJ, Sachdeva UM, Platt JM, DeMatteo RG, Simon MC, Thompson CB. 2011. Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of -ketoglutarate to citrate to support cell growth and viability. Proceedings of the National Academy of Sciences 108: 19611-19616. doi: 10. 1073/pnas.1117773108
55. Xiao X, Yu S, Li S, Wu J, Ma R, Cao H, Zhu Y, Feng J. 2014. Exosomes: Decreased Sensitivity of Lung Cancer A549 Cells to Cisplatin. PLoS ONE 9: e89534. doi: 10.1371/journal.pone.0089534
56. Yang L, Moss T, Mangala LS, Marini J, Zhao H, Wahlig S, Armaiz-Pena G, Jiang D, Achreja A, Win J, Roopaimoole R, Rodriguez-Aguayo C, Mercado-Uribe I, Lopez-Berestein G, Liu J, Tsukamoto T, Sood AK, Ram PT, Nagrath D. 2014. Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer. Molecular Systems Biology 10: 728. doi: 10.1002/msb.20134892
57. Ying H, Kimmelman AC, Lyssiotis CA, Hua S, Chu GC, Fletcher-Sananikone E, Locasale JW, Son J, Zhang H, Coloff JL, Yan H, Wang W, Chen S, Viale A, Zheng H, Paik Ji-hye, Lim C, Guimaraes AR, Martin ES, Chang J, et al. 2012. Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism. Cell 149: 656-670. doi: 10.1016/j.cell.2012.01.058
58. Yoshimoto M, Waki A, Yonekura Y, Sadato N, Murata T, Omata N, Takahashi N, Welch MJ, Fujibayashi Y. 2001. Characterization of acetate metabolism in tumor cells in relation to cell proliferation: Acetate metabolism in tumor cells. Nuclear Medicine and Biology 28: 117-122. doi: 10.1016/S0969-8051(00)00195-5
59. Zaidi N, Swinnen JV, Smans K. 2012. ATP-Citrate Lyase: A Key Player in Cancer Metabolism. Cancer Research 72: 3709-3714. doi: 10.1158/0008-5472.CAN-11-4112
60. Zhu W, Huang L, Li Y, Zhang X, Gu J, Yan Y, Xu X, Wang M, Qian H, Xu W. 2012. Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth in vivo. Cancer Letters 315: 28-37. doi: 10.1016/j. canlet.2011.10.002